Related Experiment Video

Updated: Jun 6, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Vitamin D and the heart: why we need large-scale clinical trials

Joann E Manson1

  • 1Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA. jmanson@rics.bwh.harvard.edu

Cleveland Clinic Journal of Medicine
|December 15, 2010
PubMed

Insights

Vitamin D and Omega-3 Trial (VITAL) is a large study investigating if these supplements prevent cancer and cardiovascular disease. Current evidence is limited, prompting this primary prevention research.

Area of Science:

  • Nutritional science
  • Preventive medicine
  • Clinical trials

Background:

  • Vitamin D supplementation shows potential for reducing risks of cancer, cardiovascular disease, and chronic diseases.
  • Existing evidence regarding the benefits and risks of vitamin D is limited and inconclusive.
  • Large-scale trials are needed to confirm the efficacy of nutritional agents in primary prevention.

Purpose of the Study:

  • To conduct the first large-scale randomized clinical trial on vitamin D and omega-3 fatty acids for primary prevention.
  • To investigate the effects of vitamin D and omega-3 supplementation on cancer incidence.
  • To evaluate the impact of vitamin D and omega-3 supplementation on cardiovascular disease events.

Main Methods:

  • The Vitamin D and Omega-3 Trial (VITAL) is a large-scale, randomized, placebo-controlled clinical trial.
  • Participants are recruited for the primary prevention of cancer and cardiovascular disease.
  • The trial investigates the effects of vitamin D and omega-3 fatty acid supplementation.

Main Results:

  • Recruitment is currently underway for the VITAL trial.
  • The trial aims to provide conclusive evidence on the benefits and risks of vitamin D and omega-3 supplementation.
  • Results are pending as the study progresses.

Conclusions:

  • The VITAL trial is expected to yield significant insights into the role of vitamin D and omega-3s in chronic disease prevention.
  • This study will address the current limitations in evidence regarding these nutritional agents.
  • Findings will inform public health recommendations on vitamin D and omega-3 supplementation.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...